Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Update

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 37,000 shares, an increase of 625.5% from the January 31st total of 5,100 shares. Based on an average trading volume of 82,800 shares, the short-interest ratio is presently 0.4 days.

Algernon Pharmaceuticals Trading Up 13.2 %

AGNPF traded up $0.01 on Friday, reaching $0.06. The company had a trading volume of 400 shares, compared to its average volume of 25,208. Algernon Pharmaceuticals has a 52-week low of $0.04 and a 52-week high of $0.12. The business has a 50 day simple moving average of $0.06 and a 200 day simple moving average of $0.06.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.